What is BioIQ?
Founded in 2005 and headquartered in Atlanta, Georgia, BioIQ is at the forefront of making health testing more accessible. Through its sophisticated software solutions, the company seamlessly connects individuals to vital health measurements, thereby generating deeper insights for consumers and increasing engagement touchpoints with its health service partners. BioIQ's mission is to evolve the way health measurement works, positioning itself as a key player in the digital health and wellness landscape.
How much funding has BioIQ raised?
BioIQ has raised a total of $46.5M across 6 funding rounds:
Other Financing Round
$436K
Other Financing Round
$492K
Private Equity
$10M
Private Equity
$7.1M
Unspecified
$26.5M
Debt
$2M
Other Financing Round (2009): $436K with participation from Persistence Partners
Other Financing Round (2010): $492K led by Persistence Partners
Private Equity (2015): $10M, investors not publicly disclosed
Private Equity (2016): $7.1M, investors not publicly disclosed
Unspecified (2018): $26.5M backed by HealthQuest Capital and Arboretum Ventures
Debt (2020): $2M with participation from PPP
Key Investors in BioIQ
Persistence Partners
Persistence Partners is an early-stage venture fund based in Santa Barbara and Ventura Counties that focuses on funding entrepreneurial teams capable of leveraging technology to solve problems and grow businesses. The firm has concluded its investment activities and is currently focused on cultivating its existing portfolio. Notable acquisitions from its portfolio include companies acquired by LetsGetChecked, Symphony Technology Group, and Becton, Dickinson and Company. Persistence Partners has a history of successful investments from 2006 to 2022.
HealthQuest Capital
HealthQuest Capital is a venture capital firm that invests in companies at the forefront of healthcare innovation. They focus on identifying and supporting transformative technologies and services that improve patient outcomes and reduce healthcare costs. Their investment thesis often centers on digital health, medical devices, and healthcare services that demonstrate significant market potential and a clear path to scalability.
Arboretum Ventures
Arboretum Ventures is a Midwest-based healthcare venture capital firm with over 20 years of experience in investing in innovative healthcare solutions. The firm focuses on early-stage startups in under-ventured markets, aiming to improve patient outcomes and reduce healthcare costs through strategic partnerships and investments. Their portfolio includes companies in medical devices, life science tools, and tech-enabled care delivery, with a commitment to supporting diverse teams. Arboretum Ventures seeks to create transformational impacts in healthcare by collaborating closely with entrepreneurs and investors.
What's next for BioIQ?
The substantial enterprise-level capital infusion into BioIQ signals a strategic move towards scaling its operations and enhancing its technological capabilities. With a focus on improving health measurement accessibility, the company is well-positioned to capitalize on the growing demand for personalized health solutions and remote patient monitoring. Future developments are likely to involve expanding its software platform, forging new partnerships with healthcare providers, and further integrating data analytics to provide more comprehensive health insights. This strategic backing will enable BioIQ to solidify its market leadership and drive innovation in the health tech industry.
See full BioIQ company page
